NorthRock Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$27.6K 878
2025
Q2
$27.6K Buy
+100
New +$27.2K ﹤0.01% 677

Other funds holding CME

NorthRock Partners's CME Position: Q2 2026 in Review

NorthRock Partners increased its CME Group (CME) stake by 52% in Q2 2026, buying an estimated $175K and bringing the position to 1,845 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #474.

NorthRock Partners first reported a position in CME in Q3 2019 and has held it in 17 quarters since. The position peaked at $1.12M in Q2 2025. 1,706 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • NorthRock Partners held 1,845 shares of CME Group worth $407K as of Q2 2026.
  • NorthRock Partners bought 631 CME Group shares in Q2 2026, an estimated $175K.
  • CME Group made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #474 holding.
  • NorthRock Partners first reported a position in CME Group in Q3 2019 and has held it in 17 quarters since.
  • NorthRock Partners's CME Group position peaked at $1.12M in Q2 2025.
  • 1,706 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.